EFTA02574204

From: Boris Nikolic Sent: Tuesday, August 27, 2013 6:34 PM To: Jeffrey Epstein ([email protected]) Subject: FW: Life Science companies / Gates Below is an email (middle one) in which I requested that we included Founda=ion Medicine - which was not included in the list of company KPBC wanted t= present to Bill, After I suggested that FM gets included KPBC agreed (email just below). Even after that it took me several emails more as Foundation Medicine got o=itted. Will send you those. Boris Original Messa e From: Risa Stac Sent: Friday, September 7, 2012 6:54 AM To: Boris Nikolic; Lila Ibrahim; Larry Cohen Subject: Re: Life Science companies / Gates Boris- The CEO of Trius Jeff Stein would very much like to connect with you tadn i= optimistic that we can work together to resolve issues so we can move for=ard with a relationship. Foundation Medicine is a great idea; the CEO Mike Pellini will be there! I =ill get you a full list of active life sciences companies in a few hours a=d more information on Foundation Medicine. Looking forward to seeing you next week. Risa Risa Stack, Ph.D. Partner Kleiner Perkins Caufield & Byers 2750 Sand Hill Road Assistant Barbara Bell From: Boris Nikolic 1 EFTA_R1_01744732 EFTA02574204 Date: Friday, September 7, 2012 6:40 AM To: Lila Ibrahim Cohen Cc: Risa Stack Subject: RE: Lie Science companies Gates Thank you Lila! Larry How about Foundation Medicine? Trius might be interesting as there are few issues that Foundation is tryin= to resolve. Thank you Boris From: Lila Ibrahim [mailto Sent: Friday, September 07, 2012 6:37 AM To: Boris Nikolic; Larry Cohen Cc: Risa Stack Subject: Life Science companies / Gates Larry & Boris, I'm following-up on my conversation with Larry about potential life science=companies to meet next Friday. We can meet with Trius for an update. You helped put them on a good path af=er our last meeting, but they've hit a few roadblocks. We think it's worth=a follow-up. The other companies suggested - Calixa, Novadyne, Alphavax - are more matur= and/or we've exited. In other words, we aren't actively engaged in these =ompanies. I've copied Risa Stack, one of our Life Science partners who you met in May=with Trius. She's pulling together a list of current companies to see if t=ere is 1-2 others you might be interested in. Boris -we previously passed =n meeting 3V BioSciences. We met with PacBio the day of their IPO in 2010.=We don't have many other therapeutic related investments. Thanks for your guidance. -lila <?xml version=.0" encoding=TF-8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/PropertyList-1.O.dtd"> <pl ist version=.0"> <dict> <key>conversation-id</key> <integer>264597</integer> <key>date-last-viewed</key> <integer>0</integer> <key>date-received</key> <integer>1377628469</integer> 2 EFTA_R1_01744733 EFTA02574205 <key>flags</key> <integer>8590195713</integer> <key>gmail-label-ids</key> <array> <integer>6</integer> <integer>2</integer> </array> <key>remote-id</key> <string>336162</string> </dict> </plist> 3 EFTA_R1_01744734 EFTA02574206